FDA could furlough 40% of employees, slow drug reviews under partial shutdown

A lapse of federal funding would mean a partial shutdown at FDA with the potential to slow approvals and advisory committee meetings stretching beyond the length of the impasse.

While negotiations in Washington continue, the possibility for either a short- or long-term budget fix before

Read the full 440 word article

User Sign In